FDA Progress
Our regulatory team has engaged in multiple FDA interactions to strategically position the technology for market clearance and adoption.
NSF Recognition
Awarded both NSF Phase I and Phase II SBIR funding, validating our technical innovation, commercial potential, and ability to translate breakthrough research into clinically impactful products.
Research Excellence
Backed by clinical-grade product development and regulatory expertise, our device delivers immediate phenylalanine results in an at-home, or point-of-care setting.
Our Mission
PKU affects individuals who cannot break down certain amino acids. Our innovative device aims to revolutionize PKU management, improving quality of life for patients worldwide.
Dedicated to Making a Difference
Empowering PKU patients and healthcare providers
The Omaroon Platform
A comprehensive healthcare platform connecting patients, doctors, and administrators for seamless PKU management.
Real-time PKU Monitoring
Track phenylalanine levels instantly from your device and view trends over time.
Connected Care
Seamlessly communicate with your healthcare provider through our secure platform.
HIPAA Compliant
Your health data is protected with enterprise-grade security and encryption.